Fred Nsubuga
Department of Vaccines and Immunization, Ministry of Health, Kampala, UgandaPublications
-
Research Article
Author(s): Fred Nsubuga40813*, Driwale Alfred40814, Immaculate Ampeire40816, Samuel Ofori Gyasi40817 and Steven Ndugwa Kabwama40818
Methods: Vaccine safety surveillance is increasingly becoming a critical area in national immunization programs. Uganda conducted a Measles-Rubella catchup and Polio mass vaccination campaign between 16 and 20 October 2019. We conducted a descriptive analysis of the adverse events following immunization reported following this campaign to inform policy updates. The target age-group for the campaign was children aged 9 months to 14 completed years, while the target age-group for polio campaign was 0-59 months. We conducted active search for the serious adverse event following immunization that were reported. Results: Among the 19,241,348 persons vaccinated during the Measles-Rubella catch-up and Polio mass campaign, 10,612,278 (55%) received MR vaccine alone; while 8,629,070 (45%) received either bivalent oral polio vaccine (bOPV) alone or MR.. Read More»
DOI: 10.31858/0975-8453.13.8.539-543